Background: Assessing the effectiveness and safety of Tai Chi for coronavirus disease 2019 (COVID-19) in recovery period is the main purpose of this systematic review protocol.
Methods: The following electronic databases will be searched from inception to April 2020: MEDLINE, Ovid, EMBASE, the Cochrane Library, the Allied and Complementary Medicine Database, Chinese National Knowledge Infrastructure, Chinese Biomedical Literature Database, VIP Database and Wanfang Database. In addition, Clinical trial registries, like the Chinese Clinical Trial Registry, the Netherlands National Trial Register and ClinicalTrials.gov, will be searched for ongoing trials with unpublished data. No language restrictions will be applied. The primary outcome will be the time of disappearance of main symptoms (including fever, asthenia, cough disappearance rate, and temperature recovery time), and serum cytokine levels. The secondary outcome will be the accompanying symptoms (such as myalgia, expectoration, stuffiness, runny nose, pharyngalgia, anhelation, chest distress, dyspnea, crackles, headache, nausea, vomiting, anorexia, diarrhea) disappear rate, negative COVID-19 results rate on 2 consecutive occasions (not on the same day), CT image improvement, average hospitalization time, occurrence rate of common type to severe form, clinical cure rate, and mortality. Two independent reviewers will conduct the study selection, data extraction and assessment. Review manager software V.5.3 will be used for the assessment of risk of bias and data synthesis.
Results: The results will provide a high-quality synthesis of current evidence for researchers in this subject area.
Conclusion: The conclusion of the study will provide an evidence to judge whether Tai Chi is effective and safe for COVID-19 in recovery period.
Ethics And Dissemination: This protocol will not evaluate individual patient information or infringe patient rights and therefore does not require ethical approval. Results from this review will be disseminated through peer-reviewed journals and conference reports.PROSPERO registration number CRD42020181456.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592991 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000021459 | DOI Listing |
Similar Publications
Objective: We aimed to Investigate physical activity's effects on inhibitory control in adult attention deficit hyperactivity disorder (ADHD).The benefits of physical activity on the inhibitory control of adult ADHD were explored in the hope of providing some suggestions for approaches to treating adult ADHD.
Methods: We searched the databases PubMed, Web of Science, CNKI and Wanfang for randomised controlled trials (RCTs) of the effect of physical activity on inhibitory control in adults with ADHD, using PRISMA guidelines.
The effect of Gyrokinesis exercise on fatigue and sleep quality in female office workers.
J Exerc Rehabil
February 2025
Department of Physiology, College of Medicine, Kyung Hee University, Seoul, Korea.
Fatigue is a state of difficulty maintaining voluntary activity. Cortisol, which is essential for stress regulation, can cause tissue damage when elevated for long periods of time, which is a common problem for office workers in stressful environments. Sleep quality is important for health and cognitive function, while sleep deprivation increases the risk of physical and mental health disorders.
View Article and Find Full Text PDFA B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.
Nat Med
March 2025
Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.
Antibody-drug conjugates (ADCs) have emerged as a transformative modality in the treatment of solid tumors. YL201, a novel B7H3-targeting ADC, leverages a tumor microenvironment activable linker-payload platform, coupled with a novel topoisomerase 1 inhibitor via a protease-cleavable linker. Here we report the findings from a large-scale, global, multicenter, phase 1 trial evaluating the safety, pharmacokinetics and preliminary efficacy of YL201 in patients with advanced solid tumors refractory to standard therapies.
View Article and Find Full Text PDFEffects of Tai Chi Versus General Aerobic Exercise on Depressive Symptoms and Serum Lipid Levels Among Older Persons With Depressive Symptoms: A Randomized Controlled Study.
J Sport Exerc Psychol
March 2025
Department of Nursing, West China Second University Hospital, Sichuan University, Chengdu, SC, China.
Tai Chi, a mindfulness-based aerobic exercise, may alleviate depressive symptoms and improve physiological markers in older adults. However, its distinct effects compared with general aerobic exercise remain unclear. To compare the effects of Tai Chi and general aerobic exercise on depressive symptoms and serum lipid levels in community-dwelling older adults with mild to moderate depression, a randomized controlled trial was conducted.
View Article and Find Full Text PDFWhich specific modes of exercise training are most effective for breast related cancer fatigue? Network meta-analysis.
Front Oncol
February 2025
Early Intervention Ward, The Third People's Hospital of Ganzhou, Ganzhou, Jiangxi, China.
Objective: The objective of this study was to examine the impact of various exercise modalities on Cancer-Related Fatigue (CRF) among breast cancer patients.
Methods: A computerized search was conducted on databases including PubMed, Embase, Cochrane Library, Web of Science, CNKI, VIP, and Wanfang Database up to October 2023. Selection criteria were applied to include or exclude studies, resulting in the inclusion of 65 articles for comparison of the effects of 12 distinct exercise interventions on individuals with breast cancer.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.